Federal Supply Schedule 36F79725D014E

Award Date 12/2/24
Last Date to Order 5/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The prime contractor is Quallent Pharmaceuticals Health, LLC, a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $25,000.00 and a period of performance through...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The prime contractor is Usantibiotics LLC, a for-profit organization. The contract is an interim agreement with a ceiling value of $25,000.00 and a period of performance through April 1, 2023. The contract does...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV award is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at a ceiling of $500,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The prime contractor for this multiple-award contract is Usantibiotics LLC, a for-profit organization located in Alpharetta, Georgia. The contract has a period of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Invivyd, Inc. The contract has a ceiling value of $225,000.00 and a period of performance from November 15, 2024 to November 14, 2029. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. The scope of the contract includes the delivery of these medical...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the Department of Veterans Affairs. The contract was awarded to Apnar Pharma, LP, a minority-owned, small disadvantaged business, for the provision of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a ceiling value of $2,225,000.00 and a period of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract has a ceiling value of $419,690.00 and a period of performance ending on September 1, 2027. The prime contractor is Altathera Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The purpose of this FSS contract is to provide the VA VISN 12 with "Drugs,...
This federal contract IDV is a Federal Supply Schedule (FSS) Contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract was awarded to Methapharm Inc., a foreign-owned for-profit organization, on April 1, 2022, with an ultimate completion date of December 31, 2027 and a ceiling value of $811,760.00. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and is for the...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at a ceiling of $250,000.00, was awarded to TWI Pharmaceuticals USA, Inc. on February 1, 2023 with a period of performance through January 31, 2028. The contract is for FSS 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS," indicating that the scope includes the...
  • 36F79725D014E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

This federal contract IDV is a Federal Supply Schedule (FSS) award under Schedule 65 I B for Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Meitheal Pharmaceuticals, Inc., a for-profit foreign-owned manufacturer.

The contract has a ceiling value of $25,000.00 and a period of performance from the award date of December 2, 2024 through May 31, 2025. The contract aims to procure interim pharmaceutical and hematology-related products and services for VISN 12. While no set-asides were used, this is a multiple award FSS, allowing for task orders and pricing to be competed among the eligible vendors on the schedule.

Generated 3/9/25, 9:45 AM